CEO of Novartis’ generics unit quits, sparking sale speculation

CEO of Novartis’ generics unit quits, sparking sale speculation

Source: 
Pharmaforum
snippet: 

Richard Francis is stepping down as CEO of Novartis’ generics and biosimilars division Sandoz at the end of March, sparking further speculation about the unit’s future.